Biosimilar Solutions is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets, lasered focus on affordability, increasing patient access with Uncompromising Quality. Biosimilar product development poses a number of scientific, regulatory and technical challenges that distinguish it from traditional, small-molecule generic product development. We believe our world class team of biologic therapeutic developers and renowned scientists gives us the critical capabilities to successfully address the complexities underlying these challenges. Our team includes industry veterans with decades of experience in pioneering biologics companies, such as Amgen and Genentech, where they were responsible for leading, and in some cases establishing, these organizations’ core capabilities in process development, protein manufacturing and analytical research and development. Senior members of our internal team have contributed to the filing of over 100 Investigational New Drug applications, or INDs, and over 40 marketing applications, including those for Enbrel, the originator product for our lead biosimilar product candidate. We have also assembled a distinguished Scientific Advisory Board of leading scientists who are acknowledged experts in their respective fields.
Company Details
- Founded
- -
- Address
- 1027 Alabama Street, Vallejo,california 94590,united States
- Industry
- Biotechnology
- HQ
- Vallejo, California
Biosimilar Solutions Questions
Biosimilar Solutions's website is https://www.biosimilarsolutions.com
Biosimilar Solutions's LinkedIn profile is https://www.linkedin.com/company/biosimilar-solutions
Biosimilar Solutions's industry is
Biotechnology
Biosimilar Solutions's top competitors are
Proantek Research Laboratories Private Limited,
East Ocyon Bio Private Limited,
Solx,
Cytoimmune Therapeutics,
Ocyonbio,
Eqval Group, Inc,
Biosimilar Development,
Biosimilar Sciences India Llp,
Kashiv Biosciences Llc,
Biosciences Corp Llc.
Biosimilar Solutions's categories are Biotechnology
Biosimilar Solutions's founding year is 2019
